European Biologics Training Course 2024
EUFOREA presents its first edition of the European Biologics Hybrid Training Course taking place at the Royal Academy of Medicine in Brussels, Belgium, on Friday, 1st of March 2024. This practical, hybrid training course is designed to increase engagement and understanding of biologics among healthcare professionals (ENT specialists, pulmonologists, and allergologists) treating patients with uncontrolled type 2 diseases including Asthma, Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) and Atopic Dermatitis (AD).
The course is accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 6.0 European CME credits (ECMEC®s).
The European Biologics Training Course 2024 is now available on-demand on our e-Academy platform!
Reasons to attend
- Identify patients with uncontrolled asthma/CRSwNP as ‘fit for biologics’
- A unique programme with innovative lectures beyond the efficacy of biologics
- World-leading faculty from Europe and the United States
- Improve understanding and ability to start a biologic treatment, follow up with the patient, and evaluate the success of treatment
- Learn communication skills and information sharing with patients started on biologics
- Become EUFOREA-certified
Key learning objectives
- Practical considerations on biologics for asthma and CRSwNP
- Guidance in the choice and follow-up of a biologic for asthma and CRSwNP
European Biologics Course is meant for all:
- Specialists in pulmonology, allergology, ENT and paediatrics
- Specialists-in-training in pulmonology, ENT, allergology and paediatrics
Participants & Faculty Feedback
This masterclass shows the enormous importance of lower and upper airways HPC working together, although we have had a combined clinic with our pulmonologists already for 20 years, I learned so much. It was a wonderful experience. Thanks to the whole EUFOREA TEAM!
Prof. Wytske Fokkens
I have never experienced a training course where Pulmonologists, Allergologists and ENTs from different continents shared knowledge on innovative treatments in such an authentic, inspirational and honest way, serving the purpose of optimal patient care.
Prof. Peter Hellings
The collaboration among the faculty members of ENT surgeons, pulmonologists and allergologists showed the way for the future, which induced willingness to collaborate among the participants. Multidisciplinary collaboration at its best increases the forum of learning, and the everyday clinic and I am sure that most participants and faculty members brought new knowledge home to the clinic from the very basic immunology to treatment decisions.
Prof. Vibeke Backer
EUFOREA's inaugural Biologics Training Course for airway diseases heralded a new era of collaboration among allergists, pulmonologists, industry experts, and rhinologists from Europe and the US. Through lively discussions on indications, benefits, adverse effects, and optimal timing of biological therapies, the course shared invaluable knowledge and fostered a sense of camaraderie and shared purpose. Against the backdrop of the beautiful Royal Academy of Medicine of Belgium (Palais des Académies), participants experienced a blend of intellectual stimulation and enjoyable engagement, ensuring that learning was not only effective but also enjoyable. I loved being a part of this experience.
Prof. Anju T. Peters
Photo Gallery
EUFOREA News Show on the Announcement of the European Biologics Training Course 2024
Accreditation Statement
The European Biologics Training Course 2024, Brussels, Belgium AND Virtual, Belgium, 01/03/2024 - 01/03/2024 organized by the European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA) has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) for a maximum of 6.0 European CME credits (ECMEC®s). Each medical specialist should claim only those credits that he/she actually spent on the educational activity.
Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME® credits to AMA credits can be found at https://edhub.ama-assn.org/pages/applications.
Live educational activities occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC® credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
Information regarding the conversion of EACCME® credits
Credit will be converted based on one (1) hour of participation equalling one credit for all activities. Physicians wishing to convert EACCME® credits to AMA PRA Category 1 Credit™ will be required to access the AMA website at https://edhub.ama-assn.org/pages/applictations to obtain the necessary paperwork and instructions. Physicians and other healthcare professionals will be required to pay a processing fee to the AMA.
For other countries, please contact the relevant national/regional accreditation authority.
EUROPEAN UNION OF MEDICAL SPECIALISTS (UEMS)
EUROPEAN ACCREDITATION COUNCIL ON CME (EACCME®)
RUE DEL'INDUSTRIE 24, BE - 1040 Brussels
T +32 2 649 51 64
eaccme.uems.eu - accreditation@uems.eu
UEMS - Union Europeenne des Medecins Specialists
IBAN BE28 0001 3283 3820 | BIC (SWIFT) BPOTBEB1 | VAT no BE 0469.067.848
RPM Bruxelles-Brussels EU Transparency Register ID 219038730914-92
Physicians and other healthcare professionals will be required to pay a processing fee to the AMA. For other countries, please contact the relevant national/regional accreditation authority.